The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
BRCA1 Mutations in Primary Breast and Ovarian Carcinomas
Abstract
Loss of heterozygosity data from familial tumors suggest that BRCA1 , a gene that confers susceptibility to ovarian and early-onset breast cancer, encodes a tumor suppressor. The BRCA1 region is also subject to allelic loss in sporadic breast and ovarian cancers, an indication that BRCA1 mutations may occur somatically in these tumors. The BRCA1 coding region was examined for mutations in primary breast and ovarian tumors that show allele loss at the BRCA1 locus. Mutations were detected in 3 of 32 breast and 1 of 12 ovarian carcinomas; all four mutations were germline alterations and occurred in early-onset cancers. These results suggest that mutation of BRCA1 may not be critical in the development of the majority of breast and ovarian cancers that arise in the absence of a mutant germline allele.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Research works printed but not linked: 18
- CROPP, C.S., IDENTIFICATION OF 3 REGIONS ON CHROMOSOME-17Q IN PRIMARY HUMAN BREAST CARCINOMAS WHICH ARE FREQUENTLY DELETED, CANCER RESEARCH 53: 5617 (1993).
- CROPP, C.S., EVIDENCE FOR INVOLVEMENT OF BRCA1 IN SPORADIC BREAST CARCINOMAS, CANCER RESEARCH 54: 2548 (1994).
- EASTON, D.F., GENETIC-LINKAGE ANALYSIS IN FAMILIAL BREAST AND OVARIAN-CANCER - RESULTS FROM 214 FAMILIES, AMERICAN JOURNAL OF HUMAN GENETICS 52: 678 (1993).
- ECCLES, D.M., ALLELE LOSSES ON CHROMOSOME-17 IN HUMAN EPITHELIAL OVARIAN-CARCINOMA, ONCOGENE 5: 1599 (1990).
- FUTREAL, P.A., DETECTION OF FREQUENT ALLELIC LOSS ON PROXIMAL CHROMOSOME-17Q IN SPORADIC BREAST-CARCINOMA USING MICROSATELLITE LENGTH POLYMORPHISMS, CANCER RESEARCH 52: 2624 (1992).
- FUTREAL, P.A., ISOLATION OF A DIVERGED HOMEOBOX GENE, MOX1, FROM THE BRCA1 REGION ON 17Q21 BY SOLUTION HYBRID CAPTURE, HUMAN MOLECULAR GENETICS 3: 1359 (1994). · DOI
- GLEBOV, O.K., FREQUENT P53 GENE-MUTATIONS AND NOVEL ALLELES IN FAMILIAL BREAST-CANCER, CANCER RESEARCH 54: 3703 (1994).
- 10.1126/science.2270482 · DOI · Paper page
- JACOBS, I.J., A DELETION UNIT ON CHROMOSOME-17Q IN EPITHELIAL OVARIAN-TUMORS DISTAL TO THE FAMILIAL BREAST OVARIAN-CANCER LOCUS, CANCER RESEARCH 53: 1218 (1993).
- KELSELL, D.P., GENETIC-ANALYSIS OF THE BRCA1 REGION IN A LARGE BREAST OVARIAN FAMILY - REFINEMENT OF THE MINIMAL REGION CONTAINING BRCA1, HUMAN MOLECULAR GENETICS 2: 1823 (1993). · DOI
- KNUDSON, A.G., RETINOBLASTOMA - PROTOTYPIC HEREDITARY NEOPLASM, SEMINARS IN ONCOLOGY 5: 57 (1978).
- LYNCH, H.T., HEREDITARY CARCINOMA OF THE OVARY AND ASSOCIATED CANCERS - A STUDY OF 2 FAMILIES, GYNECOLOGIC ONCOLOGY 36: 48 (1990). · DOI
- 10.1126/science.7545954 · DOI
- MIYOSHI, Y, HUM MOL GENET 1: 229 (1992). · DOI · Paper page
- SAITO, H, DETAILED DELETION MAPPING OF CHROMOSOME 17Q IN OVARIAN AND BREAST CANCERS - 2-CM REGION ON 17Q21.3 OFTEN AND COMMONLY DELETED IN TUMORS, CANCER RESEARCH 53: 3382 (1993).
- SATO, T, ALLELOTYPE OF BREAST-CANCER - CUMULATIVE ALLELE LOSSES PROMOTE TUMOR PROGRESSION IN PRIMARY BREAST-CANCER, CANCER RESEARCH 50: 7184 (1990).
- SATO, T, ACCUMULATION OF GENETIC ALTERATIONS AND PROGRESSION OF PRIMARY BREAST-CANCER, CANCER RESEARCH 51: 5794 (1991).
- SMITH, S.A., ALLELE LOSSES IN THE REGION 17Q12-21 IN FAMILIAL BREAST AND OVARIAN-CANCER INVOLVE THE WILD-TYPE CHROMOSOME, NATURE GENETICS 2: 128 (1992). · DOI · Paper page
Cited by
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Self-citationABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics
McPherson, K. (2000) · BMJ · doi:10.1136/bmj.321.7261.624 · Cited by 1,570
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
Autophagy in malignant transformation and cancer progression
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182
BRCA1 and BRCA2: 1994 and beyond
Narod, S. A., & Foulkes, W. D. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1431 · Cited by 967
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
Prakash, R., Zhang, Y., Feng, W., & Jasin, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016600 · Cited by 869
Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members
Kim, S.-T., Lim, D.-S., Canman, C. E., & Kastan, M. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37538 · Cited by 810
Yoshida, K., & Miki, Y. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02195.x · Cited by 753
Self-citationPrinciples of Protein−Protein Interactions: What are the Preferred Ways For Proteins To Interact?
Keskin, O., Gursoy, A., Ma, B., & Nussinov, R. (2008) · Chemical Reviews · doi:10.1021/cr040409x · Cited by 697
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
Welcsh, P. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.705 · Cited by 648
BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
Zhao, W., Steinfeld, J. B., Liang, F., Chen, X., Maranon, D. G., Jian Ma, C., Kwon, Y., Rao, T., Wang, W., Sheng, C., et al. (2017) · Nature · doi:10.1038/nature24060 · Cited by 393
Catteau, A., Harris, W. H., Xu, C.-F., & Solomon, E. (1999) · Oncogene · doi:10.1038/sj.onc.1202509 · Cited by 354
The role of BRCA1 in DNA damage response
Wu, J., Lu, L.-Y., & Yu, X. (2010) · Protein & Cell · doi:10.1007/s13238-010-0010-5 · Cited by 235
Structure of the BRCT Repeats of BRCA1 Bound to a BACH1 Phosphopeptide
Shiozaki, E. N., Gu, L., Yan, N., & Shi, Y. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00238-2 · Cited by 174
MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes
Fujii, S., Tokita, K., Wada, N., Ito, K., Yamauchi, C., Ito, Y., & Ochiai, A. (2011) · Oncogene · doi:10.1038/onc.2011.118 · Cited by 137
Heijink, A. M., Talens, F., Jae, L. T., van Gijn, S. E., Fehrmann, R. S. N., Brummelkamp, T. R., & van Vugt, M. A. T. M. (2019) · Nature Communications · doi:10.1038/s41467-018-07927-y · Cited by 140
Disabled-2 inactivation is an early step in ovarian tumorigenicity
Fazili, Z., Sun, W., Mittelstaedt, S., Cohen, C., & Xu, X.-X. (1999) · Oncogene · doi:10.1038/sj.onc.1202649 · Cited by 116
Kumaraswamy, E., & Shiekhattar, R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00961-07 · Cited by 110
Label-free DNA detection with a nanogap embedded complementary metal oxide semiconductor
Kim, C.-H., Jung, C., Lee, K.-B., Park, H. G., & Choi, Y.-K. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/13/135502 · Cited by 103
A Zinc-binding Domain Involved in the Dimerization of RAG1
Rodgers, K. K., Bu, Z., Fleming, K. G., Schatz, D. G., Engelman, D. M., & Coleman, J. E. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0382 · Cited by 100
McClintock, M. K., Conzen, S. D., Gehlert, S., Masi, C., & Olopade, F. (2005) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/60.special_issue_1.32 · Cited by 88
Glover, J. N. M. (2006) · Familial Cancer · doi:10.1007/s10689-005-2579-z · Cited by 57
Wei, L., Lan, L., Yasui, A., Tanaka, K., Saijo, M., Matsuzawa, A., Kashiwagi, R., Maseki, E., Hu, Y., Parvin, J. D., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02037.x · Cited by 48
NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway
Wilson, K. A., & Stern, D. F. (2008) · Cell Cycle · doi:10.4161/cc.7.22.7102 · Cited by 43
The European opposition against the BRCA gene patents
Matthijs, G. (2006) · Familial Cancer · doi:10.1007/s10689-005-2580-6 · Cited by 30
Metadata
- Authors
- Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., Eddington, K., McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Söderkvist, P., Terry, L., Jhanwar, S., Berchuck, A., Iglehart, J. D., Marks, J., Ballinger, D. G., Barrett, J. C., Skolnick, M. H., Kamb, A., & Wiseman, R.
- Venue
- Science
- Published
- 1994-10-07
- Volume
- 266
- Issue
- 5182
- Pages
- 120-122
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2036546668
- Cited by
- 1,205
- References
- 1
- FWCI
- 51.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.